Answers are grounded in this paper and cite their sources.
Objective: To analyze the scientific evidence available on the pathophysiological mechanisms involved in the association between SARS-CoV-2 infection and stroke, integrating the main biological processes described in the literature. Methods: This is an integrative literature review, conducted according to the method proposed by Whittemore and Knafl, with searches performed in the PubMed/MEDLINE, BVS, and CAPES Periodicals Portal databases, using the descriptors COVID-19, Stroke, and Pathophysiology, combined with the AND operator, covering publications from January 2021 to June 2026. Results: Of the 711 studies identified, 14 composed the final sample, revealing seven recurring pathophysiological axes: renin-angiotensin-aldosterone system dysregulation, cerebral endotheliopathy, immunothrombosis, blood-brain barrier degradation, neuroinvasion and mitochondrial dysfunction, systemic hypoxia with cardioembolism, and persistent endothelial dysfunction in long COVID, revealing COVID-19 as a multisystemic vascular disease associated with increased cerebrovascular risk. Final considerations: This study reinforces the central role of thromboinflammation and endothelial injury in the pathophysiology of COVID-19-associated stroke, although gaps remain regarding the contribution of direct viral neuroinvasion and the duration of post-infection vascular alterations.
No takes yet. Share an insight, caveat, or question.
Brito et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: